Microbot Medical 

€1.85
156
+€0.06+3.06% Today

Statistics

Day High
1.88
Day Low
1.78
52W High
3.86
52W Low
1.35
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

12MayExpected
Q4 2025
Next
-0.07
-0.06
-0.05
-0.04
Expected EPS
-0.06797600000000001
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CY9D.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Intuitive Surgical
ISRG
Mkt Cap159.39B
Intuitive Surgical is a leading developer of robotic-assisted surgical systems, directly competing with Microbot Medical's robotic technologies aimed at improving clinical outcomes.
Medtronic
MDT
Mkt Cap97.77B
Medtronic offers robotic-assisted surgery solutions, competing in the same space as Microbot Medical with its innovative medical devices for minimally invasive procedures.
Smith & Nephew
SNN
Mkt Cap12.78B
Smith & Nephew provides advanced surgical robotics for orthopedic procedures, competing with Microbot Medical in the broader field of robotic-assisted surgeries.
Zimmer Biomet
ZBH
Mkt Cap15.93B
Zimmer Biomet Holdings, Inc. competes in the development of robotic solutions for orthopedic surgeries, a market that overlaps with Microbot Medical's target for their robotic devices.
Stryker
SYK
Mkt Cap109.33B
Stryker Corporation specializes in medical technologies, including robotic surgery systems, making it a competitor in the robotic-assisted surgical market alongside Microbot Medical.
Johnson & Johnson
JNJ
Mkt Cap532.77B
Johnson & Johnson, through its subsidiary Ethicon, is involved in the development of surgical robotics, competing with Microbot Medical's innovations in the same domain.
Boston Scientific
BSX
Mkt Cap80.16B
Boston Scientific Corporation offers products that compete in the minimally invasive medical device market, including endoscopy and interventional cardiology, areas where Microbot Medical also aims to innovate.
Abbvie
ABBV
Mkt Cap356.49B
AbbVie, while primarily known for its pharmaceuticals, has ventured into medical devices and robotics through acquisitions, indirectly competing with Microbot Medical's focus on robotic surgical solutions.
Alphabet
GOOGL
Mkt Cap4.85T
Alphabet Inc., through its Verily life sciences division, is exploring robotic surgery and other medical technologies, making it a potential future competitor in the innovative medical robotics space where Microbot Medical operates.

About

Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices such as microcatheters within the body's vasculature for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system; and Emory University, in connection with autonomous robotics in endovascular procedures. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts
Show more...
CEO
Mr. Harel Gadot
Employees
43
Country
Germany
ISIN
US59503A2042

Listings

0 Comments

Share your thoughts

FAQ

What is Microbot Medical stock price today?
The current price of CY9D.STU is €1.85 EUR — it has increased by +3.06% in the past 24 hours. Watch Microbot Medical stock price performance more closely on the chart.
What is Microbot Medical stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Microbot Medical stocks are traded under the ticker CY9D.STU.
Is Microbot Medical stock price growing?
CY9D.STU stock has risen by +2.51% compared to the previous week, the month change is a -16.74% fall, over the last year Microbot Medical has showed a -17.34% decrease.
When is the next Microbot Medical earnings date?
Microbot Medical is going to release the next earnings report on May 12, 2026.
What were Microbot Medical earnings last quarter?
CY9D.STU earnings for the last quarter are -0.04 EUR per share, whereas the estimation was -0.05 EUR resulting in a +16.67% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Microbot Medical have?
As of May 11, 2026, the company has 43 employees.
In which sector is Microbot Medical located?
Microbot Medical operates in the Health & Wellness sector.
When did Microbot Medical complete a stock split?
Microbot Medical has not had any recent stock splits.
Where is Microbot Medical headquartered?
Microbot Medical is headquartered in Hingham, Germany.